share_log

Merit Medical Systems (NASDAQ:MMSI) Lowered to Buy at StockNews.com

Merit Medical Systems (NASDAQ:MMSI) Lowered to Buy at StockNews.com

優異醫療系統 (NASDAQ: 微型指數指數) 降低於證券新聞網購買
Defense World ·  2022/12/27 02:21

StockNews.com lowered shares of Merit Medical Systems (NASDAQ:MMSI – Get Rating) from a strong-buy rating to a buy rating in a report issued on Monday morning.

在週一上午發佈的一份報告中,斯托克新聞網將默立特醫療系統公司(納斯達克代碼:MMSI-GET Rating)的股票評級從買入下調至買入。

Other research analysts also recently issued reports about the company. Canaccord Genuity Group raised their price objective on Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. Piper Sandler increased their target price on Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. Raymond James increased their target price on Merit Medical Systems from $71.00 to $72.00 and gave the company an outperform rating in a research report on Thursday, October 27th. TheStreet raised Merit Medical Systems from a c+ rating to a b- rating in a research report on Friday, September 16th. Finally, Canaccord Genuity Group cut Merit Medical Systems from a buy rating to a hold rating and dropped their target price for the company from $73.00 to $72.00 in a research report on Tuesday, December 20th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $73.50.

其他研究分析師最近也發佈了關於該公司的報告。Canaccel Genuity Group在11月7日星期一的一份報告中將Merit Medical Systems的目標價從69.00美元上調至73.00美元。派珀·桑德勒在10月27日週四的一份研究報告中將其對Merit Medical Systems的目標價從70.00美元上調至73.00美元。Raymond James將Merit Medical Systems的目標價從71.00美元上調至72.00美元,並在10月27日週四的一份研究報告中給出了該公司表現優於大盤的評級。華爾街在9月16日星期五的一份研究報告中將Merit醫療系統的評級從C+上調至B-。最後,在12月20日星期二的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的評級從買入下調至持有評級,並將該公司的目標價從73.00美元下調至72.00美元。一位研究分析師對該股的評級為持有,五位分析師對該公司的評級為買入。根據MarketBeat的數據,該股目前的共識評級為適度買入,共識目標價為73.50美元。

Get
到達
Merit Medical Systems
優點醫療系統
alerts:
警報:

Merit Medical Systems Trading Down 0.0 %

優點醫療系統公司股價下跌0.0%

Shares of NASDAQ MMSI opened at $70.85 on Monday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.19 and a current ratio of 2.35. The business's 50 day moving average price is $68.69 and its 200-day moving average price is $61.03. Merit Medical Systems has a fifty-two week low of $50.46 and a fifty-two week high of $76.14. The company has a market cap of $4.03 billion, a price-to-earnings ratio of 65.60, a PEG ratio of 2.51 and a beta of 1.02.

週一,納斯達克微星的股價開盤報70.85美元。該公司的負債權益比率為0.19,速動比率為1.19,流動比率為2.35。該業務的50日移動均線價格為68.69美元,其200日移動均線價格為61.03美元。優點醫療系統公司的股價為50.46美元,為52周低點,52周高點為76.14美元。該公司市值為40.3億美元,市盈率為65.60倍,聚乙二醇率為2.51倍,貝塔係數為1.02。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last issued its quarterly earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.11. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. The firm had revenue of $287.18 million for the quarter, compared to the consensus estimate of $273.03 million. On average, sell-side analysts expect that Merit Medical Systems will post 2.57 earnings per share for the current year.
優點醫療系統公司(納斯達克:MMSI-GET評級)最近一次發佈季度收益報告是在10月26日星期三。這家醫療器械供應商公佈本季度每股收益為0.64美元,比普遍預期的0.53美元高出0.11美元。優點醫療系統公司的股本回報率為14.14%,淨利潤率為5.43%。該公司本季度營收為2.8718億美元,而市場普遍預期為2.7303億美元。賣方分析師平均預計,Merit Medical Systems本年度每股收益將達到2.57美元。

Institutional Trading of Merit Medical Systems

功勛醫療系統的制度性交易

A number of institutional investors have recently made changes to their positions in MMSI. Crossmark Global Holdings Inc. lifted its position in Merit Medical Systems by 4.2% during the 1st quarter. Crossmark Global Holdings Inc. now owns 5,212 shares of the medical instruments supplier's stock worth $346,000 after acquiring an additional 210 shares during the period. SG Americas Securities LLC lifted its position in Merit Medical Systems by 746.0% during the 2nd quarter. SG Americas Securities LLC now owns 27,013 shares of the medical instruments supplier's stock worth $1,466,000 after acquiring an additional 23,820 shares during the period. Rhumbline Advisers lifted its position in Merit Medical Systems by 8.8% during the 2nd quarter. Rhumbline Advisers now owns 143,882 shares of the medical instruments supplier's stock worth $7,808,000 after acquiring an additional 11,616 shares during the period. Maryland State Retirement & Pension System lifted its position in Merit Medical Systems by 1.4% during the 2nd quarter. Maryland State Retirement & Pension System now owns 20,671 shares of the medical instruments supplier's stock worth $1,122,000 after acquiring an additional 295 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in Merit Medical Systems by 17.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,337 shares of the medical instruments supplier's stock worth $235,000 after acquiring an additional 647 shares during the period. Institutional investors and hedge funds own 95.38% of the company's stock.

一些機構投資者最近改變了他們在MMSI的頭寸。Crossmark Global Holdings Inc.在第一季度將其在Merit Medical Systems的頭寸提高了4.2%。在此期間,Crossmark Global Holdings Inc.增持了210股,目前持有這家醫療器械供應商5,212股股票,價值346,000美元。第二季度,SG America Securities LLC將其在Merit Medical Systems的頭寸提高了746.0%。在此期間,SG America Securities LLC額外收購了23,820股,目前擁有這家醫療器械供應商27,013股股票,價值1,466,000美元。Rhumbline Advisers在第二季度將其在Merit醫療系統公司的頭寸提高了8.8%。在此期間,Rhumbline Advisers額外收購了11,616股,現在擁有143,882股這家醫療器械供應商的股票,價值7,808,000美元。馬裏蘭州退休和養老金系統在第二季度將其在Merit醫療系統的地位提高了1.4%。馬裏蘭州退休和養老金系統現在擁有這家醫療器械供應商的20,671股股票,價值1,122,000美元,在此期間又購買了295股。最後,NISA Investment Advisors LLC在第二季度將其在Merit Medical Systems的頭寸提高了17.5%。NISA Investment Advisors LLC目前持有這家醫療器械供應商4337股股票,價值23.5萬美元,在此期間又收購了647股。機構投資者和對衝基金持有該公司95.38%的股票。

Merit Medical Systems Company Profile

優點醫療系統公司簡介

(Get Rating)

(獲取評級)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year
  • Southwest Airlines Stock, There is a Lot to Love
  • MarketBeat: Week in Review 12/19 – 12/23
  • These Steelmakers Deserve A Place On Your 2023 Watch List
  • 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
  • 美光科技預計2023年底芯片回收
  • 新年值得關注的三隻醫療保健便士股
  • 西南航空公司股票,有很多值得愛的東西
  • MarketBeat:回顧一週12/19-12/23
  • 這些鋼鐵製造商理應在2023年觀察名單上佔有一席之地

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論